Society's Fast Forward Program Funds New Biomarker Studies to Speed the Testing of New MS Therapies
November 15, 2019
November 15, 2019
NEW YORK, Nov. 15 -- The National Multiple Sclerosis Society issued the following news:
The National MS Society, through its Fast Forward drug development program, is investing in two new projects that leverage ongoing MS clinical trials that are testing new approaches to treating MS. The Fast Forward funding is being applied to search for markers in blood or spinal fluid that may indicate that the therapies are having positive effects.
The identified biomarkers, once t . . .
The National MS Society, through its Fast Forward drug development program, is investing in two new projects that leverage ongoing MS clinical trials that are testing new approaches to treating MS. The Fast Forward funding is being applied to search for markers in blood or spinal fluid that may indicate that the therapies are having positive effects.
The identified biomarkers, once t . . .